RIPK1 and Hypertension: Taking advantage of ApoESA/SA mice, a new model combining both hypercholesterolemia and hypertension that rapidly develops atherosclerosis (manuscript under submission), we examined the impact of RIPK1 inhibition on advanced atherosclerosis.